Erratum à l'article : « Place de la TEP au FDG dans le bilan des épilepsies pharmacorésistantes » [Médecine Nucléaire 2009;33(6):352-62];Erratum to "FDG PET role in the management of refractory epilepsy" [Médecine Nucléaire 2009;33:352-62] (DOI:10.1016/j.mednuc.2009.02.014);FDG PET role in the management of refractory epilepsy;Place de la TEP au FDG dans le bilan des épilepsies pharmacorésistantes

Medecine Nucleaire

Volumn 33, Issue 6, 2009, Pages 352-362

  Papathanassiou, D ^a   Domange Testard, A ^a   Thiriaux, A ^b   Bruna Muraille, C ^a   Cuif Job, A ^a   Motte, J ^b   Liehn, J C ^a  

^a INSTITUT JEAN GODINOT   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Epilepsy; FDG; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC FOCUS; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MEDICAL SPECIALIST; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; QUESTIONNAIRE; REFRACTORY EPILEPSY; SCHOOL CHILD; TEMPORAL LOBE EPILEPSY;

EID: 67349164271     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mednuc.2009.07.001     Document Type: Erratum

References (41)

1. Kilpatrick C., Cook M., Kaye A., Murphy M., and Matkovic Z. Non-invasive investigations successfully select patients for temporal lobe surgery. J Neurol Neurosurg Psychiatry 63 (1997) 327-333
2. Engel Jr. J., Van Ness P.C., Rasmussen T.B., and Ojemann L.M. Outcome with respect to epileptic seizures. In: Engel Jr. J. (Ed). Surgical treatment of the epilepsies (1993), Raven Press, New York 609-621
3. Henry T.R. Functional neuroimaging with positron emission tomography. Epilepsia 37 (1996) 1141-1154
4. Semah F., and Dupont S. La tomographie par émission de positons dans l'exploration préchirurgicale des épilepsies partielles de l'adulte. Med Nucl 23 (1999) 646-651
5. Semah F. La TEP et la TEMP pour l'étude des épilepsies. Med Nucl 30 (2006) 585-594
6. Kuhl D.E., Engel Jr. J., Phelps M.E., and Selin C. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol 8 (1980) 348-360
7. Ryvlin P., Bouvard S., Le B.D., De Lamerie G., Gregoire M.C., Kahane P., et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 121 (1998) 2067-2081
8. Semah F, Baulac M, Hasboun D, Frouin V, Mangin JF, Papageorgiou SL et al. Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron emission tomography/magnetic resonance imaging confrontation. Epilepsia 1995;36:447-56.
9. Patil S., Biassoni L., and Borgwardt L. Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med 37 (2007) 357-381
10. Theodore W.H., Sato S., Kufta C., Balish M.B., Bromfield E.B., and Leiderman D.B. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 32 (1992) 789-794
11. Lee S.K., Lee S.Y., Kim K.K., Hong K.S., Lee D.S., and Chung C.K. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol 58 (2005) 525-532
12. Ollenberger G.P., Byrne A.J., Berlangieri S.U., Rowe C.C., Pathmaraj K., Reutens D.C., et al. Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy. Eur J Nucl Med Mol Imaging 32 (2005) 1311-1316
13. O'Brien T.J., Hicks R.J., Ware R., Binns D.S., Murphy M., and Cook M.J. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy. J Nucl Med 42 (2001) 1158-1165
14. Conférence de consensus Prise en charge des épilepsies partielles pharmaco-résistantes. Mercredi 3 et jeudi 4 mars 2004, Maison de l'Unesco, Paris. http://www.has-santefr/portail/upload/docs/application/pdf/Epilepsies_long.pdf (site consulté le 5 août 2008).
15. Bartenstein P., Asenbaum S., Catafau A., Halldin C., Pilowski L., Pupi A., et al. European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. Eur J Nucl Med Mol Imaging 29 (2002) BP43-BP48
16. Knowlton R.C. The role of FDG-PET, ictal SPECT, and MEG in the epilepsy surgery evaluation. Epilepsy Behav 8 (2006) 91-101
17. Kim Y.K., Lee D.S., Lee S.K., Chung C.K., Chung J.K., and Lee M.C. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 43 (2002) 1167-1174
18. Carne R.P., Cook M.J., Macgregor L.R., Kilpatrick C.J., Hicks R.J., and O'brien T.J. "Magnetic resonance imaging negative positron emission tomography positive" temporal lobe epilepsy: FDG-PET pattern differs from mesial temporal lobe epilepsy. Mol Imaging Biol 9 (2007) 32-42
19. Plotkin M, Amthauer H, Merschhemke M, Ludemann L, Hartkop E, Ruf JG et al. Use of statistical parametric mapping of (18) F-FDG-PET in frontal lobe epilepsy. Nuklearmedizin 2003;42:190-6.
20. Kim M.A., Heo K., Choo M.K., Cho J.H., Park S.C., Lee J.D., et al. Relationship between bilateral temporal hypometabolism and EEG findings for mesial temporal lobe epilepsy: analysis of 18F-FDG PET using SPM. Seizure 15 (2006) 56-63
21. Yun C.H., Lee S.K., Lee S.Y., Kim K.K., Jeong S.W., and Chung C.K. Prognostic factors in neocortical epilepsy surgery: multivariate analysis. Epilepsia 47 (2006) 574-579
22. Casse R., Rowe C.C., Newton M., Berlangieri S.U., and Scott A.M. Positron emission tomography and epilepsy. Mol Imaging Biol 4 (2002) 338-351
23. Willmann O., Wennberg R., May T., Woermann F.G., and Pohlmann-Eden B. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis. Seizure 16 (2007) 509-520
24. Won HJ, Chang KH, Cheon JE, Kim HD, Lee DS, Han MH, et al. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR Am J Neuroradiol 1999;20:593-9.
25. O'Brien T.J., Miles K., Ware R., Cook M.J., Binns D.S., and Hicks R.J. The cost-effective use of 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy. J Nucl Med 49 (2008) 931-937
26. Buch K., Blumenfeld H., Spencer S., Novotny E., and Zubal I.G. Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization. Eur J Nucl Med Mol Imaging 35 (2008) 579-588
27. Kurian M., Spinelli L., Delavelle J., Willi J.P., Velazquez M., Chaves V.H., et al. Multimodality imaging for focus localization in pediatric pharmacoresistant epilepsy. Epileptic Disord 9 (2007) 20-31
28. DellaBadia Jr. J., Bell W.L., Keyes Jr. J.W., Mathews V.P., and Glazier S.S. Assessment and cost comparison of sleep-deprived EEG, MRI and PET in the prediction of surgical treatment for epilepsy. Seizure 11 (2002) 303-309
29. Hwang S.I., Kim J.H., Park S.W., Han M.H., Yu I.K., Lee S.H., et al. Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy. Am J Neuroradiol 22 (2001) 937-946
30. Koutroumanidis M., Hennessy M.J., Seed P.T., Elwes R.D., Jarosz J., Morris R.G., et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology 54 (2000) 1811-1821
31. Gaillard W.D., White S., Malow B., Flamini R., Weinstein S., Sato S., et al. FDG-PET in children and adolescents with partial seizures: role in epilepsy surgery evaluation. Epilepsy Res 20 (1995) 77-84
32. Swartz B.E., Brown C., Mandelkern M.A., Khonsari A., Patell A., Thomas K., et al. The use of 2-deoxy-2-[18F]fluoro-D-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy. Mol Imaging Biol 4 (2002) 245-252
33. Nelissen N., Van P.W., Baete K., Van L.K., Palmini A., Van B.H., et al. Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis. Neuroimage 32 (2006) 684-695
34. Sood S., and Chugani H.T. Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Childs Nerv Syst 22 (2006) 810-820
35. Swartz B.E., Tomiyasu U., Gado-Escueta A.V., Mandelkern M., and Khonsari A. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and postoperative outcome. Epilepsia 33 (1992) 624-634
36. Ryvlin P., Philippon B., Cinotti L., Froment J.C., Le B.D., and Mauguiere F. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18FDG-PET and 99mTc-HMPAO-SPECT. Ann Neurol 31 (1992) 650-656
37. Spencer S.S. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia 35 suppl. 6 (1994) S72-89
38. Goffin K., Dedeurwaerdere S., Van L.K., and Van P.W. Neuronuclear assessment of patients with epilepsy. Semin Nucl Med 38 (2008) 227-239
39. Hong K.S., Lee S.K., Kim J.Y., Lee D.S., and Chung C.K. Pre-surgical evaluation and surgical outcome of 41 patients with non-lesional neocortical epilepsy. Seizure 11 (2002) 184-192
40. Guidelines for neuroimaging evaluation of patients with uncontrolled epilepsy considered for surgery. Commission on Neuroimaging of the International League Against Epilepsy. Epilepsia 1998;39:1375-6.
41. Henry T.R., and Van Heertum R.L. Positron emission tomography and single photon emission computed tomography in epilepsy care. Semin Nucl Med 33 (2003) 88-104